In the circular DNA genome of the human polyomavirus BK an approximately 400 bp non-coding control region (NCCR) separates the early and late genes. The NCCR contains the origin of replication as well as the promoter/enhancer with a mosaic of cis-acting elements involved in the regulation of both early and late transcription. The NCCR has been shown to be very heterogeneous between different BK virus (BKV) strains. This may affect the host cell permissivity and oncogenic potential of a given BKV strain. Our previous studies with BKT-1B, a continuous cell line established from a BKV (Gardner) -induced hamster fibrosarcoma, revealed that the BKV DNA is integrated in the host genome in multiple copies. The sequence of the integrated BKV NCCR was substantially different from (and even contained sequences not found in) that of the BKV (Gardner) strain supposedly used to establish the BKT-1B cell line. PCR amplification, cloning and subsequent sequencing revealed that the original BKV (Gardner) stock contained at least seven different subpopulations of viral genomes. None of them had a control region 'anatomy' which was identical to either the BKV (Gardner) strain, the variant found integrated in BKT-1B cells or any previously published NCCR. In order to study the biological significance of these new BKV NCCR variants we developed a simple cassette model allowing the NCCRs of the new variants to be cloned in an identical genomic background of BKV protein-coding sequences and performed transfection studies with the recombinant genomes in non-permissive rodent cells and in semi-permissive monkey cells. The results demonstrated that the NCCR variants conferred striking differences, in both transforming capacity and host cell permissivity, to the recombinant BKV genomes. Sequence comparisons suggested genetic explanations for these differences, as well as evolutionary relationships between BKV NCCRs.
Introduction
The approximately 5.2 kbp double-stranded, circular genome of the ubiquitous (Brown et al., 1975) human polyomavirus BK (BKV) is organized and expressed as in other polyomaviruses ( Fig. 1) , with the coding regions for early (T, t antigens) and late (agno, capsid proteins VP1 3) genes separated by a non-coding control region (NCCR) of approximately 400 bp. The NCCR contains the origin of replication as well as a promoter/enhancer with a mosaic of cis-acting elements involved in the regulation of both early and late transcription (reviewed in Yoshiike & Takemoto, 1986 ).
* Author for correspondence. Present address: Department of Virology, Institute of Medical Biology, MH-Bygget, Breivika, University of Tromso, N-9037 Tromso, Norway. Fax +47 776 45350. e-mail terjet @ fag.med.uit.no During the last few years a number of different BKV strains have been isolated. DNA sequencing and restriction enzyme analyses have, with few exceptions, revealed a strong sequence conservation in the proteincoding regions of the genome (Seif et al., 1979; Yang & Wu, 1979a, b; Tavis et al., 1989; Sugimoto et al., 1990; Jin et al., 1993) , whereas the NCCRs exhibit considerable variation between different BKV isolates. It should be added though, that relatively few BKV strains have been sequenced completely and variation in coding sequences, with biological consequences, has been demonstrated for mouse polyomavirus (Dubensky et al., 1991 ; . Biochemical and genetic studies have identified an assortment of individual genetic elements that may contribute to the biological activities of the BKV NCCR (Watanabe & Yoshiike, 1986; Deyerle et al., 1987; Cassil & Subramani, 1988; Deyerle & Subramani, 1988; Grinell et al., 1988; Markowitz & Dynan, 1988; Thick lines represent the coding sequences for BKV proteins. The putative agnoprotein has been omitted. The broken lines represent the spliced-out regions. The numbering is according to Yoshiike & Takemoto (1986) , but includes the 43 bp region which is not present in the Dunlop strain (Yang & Wu, 1979b) . The restriction sites for the endonucleases EcoRI (E), HindlII (H) and SacI (S) are indicated.
1989; Chakraborty & Das, 1989) . It was proposed that the NCCR hypervariability was due to recombinational events during replication, resulting in different duplications and deletions of the same basic sequences (reviewed in Yoshiike & Takemoto, 1986) . Most BKV NCCRs that have been PCR amplified and sequenced directly from human urine, without cell culture passages, contain no duplications and/or deletions of common sequence motifs (Rubinstein et al., 1987; Sundsfjord et al., , 1994 Fla~gstad et al., 1991 ; Markowitz et al., 1991 ; Negrini et al., 1991) . BKV strains with such linear NCCR anatomy became considered to be BKV archetypes, the prototype of which is BK¥ (WW) (Rubinstein et al., 1987) . The promoter/enhancer of such strains was arbitrarily divided into three sequence blocks called, starting from the early side, P(68 bp)-Q(39 bp)-R(63 bp) (Markowitz & Dynan, 1988) . This nomenclature was later extended by including the origin/early leader, O (142 bp), and the late leader, S(63 bp), sequences (J. I. Johnsen et al., unpublished results; Sundsfjord et al., 1994; Ferguson & Subramani, 1994) . The nomenclature and anatomy of BKV NCCRs are illustrated in Fig. 3 .
All BKV NCCRs analysed so far may be envisaged as having evolved from that of BKV (WW) by repeated duplications and deletions of the basic O-P-Q-R-S blocks, although the exact mechanism is unknown (Markowitz et al., 1990) . Mixed infection studies with NCCR variants of simian virus 40 (SV40) have shown that illegitimate recombination between heterologous viral genomes can give rise to new variants (Clarke & Herr, 1987) . It may be speculated that the NCCR heterogeneity of different BKV strains is biologically reflected in the ability of polyomaviruses to adapt to new cellular environments, because duplications, deletions and new junctions of the P, Q and R sequence blocks create new, both proven and putative, binding sites for transcription factors. It is conceivable that such variation may influence the relative efficiency of viral transcription and replication in different host cells and hence their permissivity and oncogenic potential in cell cultures as well as in the human organism.
BKV was first isolated from the urine of a kidney transplant recipient (Gardner et al., 1971) . This BKV strain remained a laboratory reference strain for biological experiments. Part of its genomic DNA was sequenced several years and many cell culture passages later (Dhar et al., 1978; Yang & Wu, 1979a) . As indicated in Fig. 3 it contained an NCCR with the anatomy O142-P6s-Pso-P6s-Q39-S63. In this communication we demonstrate the NCCR heterogeneity in a cell culture passaged stock of supposed BKV (Gardner) , document seven new NCCR variants and propose a model for their evolution. Having developed a cassette cloning strategy, we made recombinant viral genomes with the new NCCR variants cloned into an identical genomic background and demonstrated distinct differences in host cell permissivity and transforming potential governed by the individual NCCR variants.
Methods
Origin of the BKV stock. The BKV-transformed hamster cell line BKT-1B has been used for studies on transcriptional control and expression . This cell line was established, in the laboratory of one of us (R. M.), by subcutaneous inoculation of a Vero cell-passaged BKV (Gardner) stock received from Dr Sylvia Gardner, and originating from the first BKV isolate (Gardner et al., 1971) . Local fibrosarcomas developed and the turnout tissue was used to establish the BKT-1B cell line, which has a malignantly transformed phenotype (Sten et al., 1976) , expresses large T antigen constitutively and contains multiple copies of integrated BKV DNA sequences in the genome (Moens et al., I990) . Comparison of the BKV NCCR found integrated in the BKT-1B cellular genome with that of BKV (Gardner) used to establish the cell line, revealed major differences (see Fig. 3 b) . Most notable was the presence of R-block sequences, which are totally absent in the published BKV (Gardner) sequence (Dhar et al., 1978; Yang & Wu, 1979a) .
With this background, it was decided to analyse the BKV NCCRs in the Veto cell passage used to establish the BKT-1B cell line. As it turned out, the specific BKV (Gardner) preparation used to inoculate the hamsters was no longer available. A harvested, infectious Vero culture medium at the same passage level was available and was made the basis for the studies described. This BKV (Gardner) preparation had been stored at -70 °C since the hamster inoculations were performed in 1973.
PCR amplification and DNA sequencing of BKV NCCRs. Prior to PCR amplification 5 ~tl of the virus preparation was diluted to 100 ~tl with distilled H20 and boiled for 10 min to disrupt cells and virus particles. Of each sample, 2 lal was amplified with 5 pmol of each primer BKTT-1 (5' AAGGTCCATGAGCTCCATGGATTCTTCC 3') and BKTT-2 (5' CTAGGTCCCCCAAAAGTGCTAGAGCAGC 3'). These primers are complementary to the early T/t antigen and the late VP2-coding sequences, respectively (Fl~egstad et al., 1991) . PCR was performed in a 50 gl reaction volume containing 1.25 U of Taq polymerase (Perkin Elmer Cetus) in the recommended buffer with 2.5 mM-MgC12. Amplification of viral DNA was achieved by 40 cycles of 1 min at 94 °C, 2 min at 55 °C and 3 min at 72 °C following an initial 5 min denaturation step. All reactions were performed in parallel with negative and positive controls, in a laboratory exclusively used for PCR. All reagents were pretested for the presence of polyomavirusspecific DNA and the general precautions outlined by Kwok (1990) were followed.
For each sample 10gl of the amplified DNA product was electrophoresed on 2 % agarose gels and visualized by UV fluorescence after staining with 1 lag/ml ethidium bromide. Different DNA fragments were purified from agarose and digested with Sad, snbcloned into M 13 vectors (Pharmacia) and sequenced by the dideoxynucleotide chain-termination method using Sequenase (USB).
Plasmid constructions. The cassette model for examination of different BKV NCCR variants in a common background of BKV protein-coding sequences was constructed from a pGEM3-Zf(-) derived plasmid, pBKV(TU), containing the BKV(TU) genome cloned into the unique EeoRI site. The BKV genome contains three SacI restriction sites. Two of the sites are located on either side of the NCCR (Fig. 1) . Partial digestion of pBKV(TU) with SacI generates a 7860 bp DNA fragment containing only the protein-coding sequences of BKV, allowing ligation of SacI-digested NCCR PCR products. Recombinant genomes were made with the following NCCR variants, CRV 102 105, PQ, BKT-1B , TU and WWT (Fl~egstad et al., 1991) . The resulting plasmids were called pBKV102, pBKVI03, pBKV104, pBKV105, pBKVPQ, pBKV-1B, pBKV(TU) and pBKVWWT.
Prior to DNA transfections the recombinant BKV-containing plasmids were digested with EcoRl (to free the BKV DNA), purified by gel electrophoresis and GeneClean (BIO101), and recircularized.
Cell culture conditions, transfection assays and quantification of BKVcontaining cells. Vero (ATCC CCL81) cells were cultured in Eagle's MEM supplemented with 1% HEPES, 2 mM-glutamine, 200 U penicillin, 100 mg streptomycin/ml and 5% fetal calf serum (FCS), whereas NIH 3T3 (ATCC CCL1658) cells were cultured in Dulbecco's MEM containing the same supplements as above.
Vero cells were transfected at 60 % confluence by the DEAE-dextran method using 50 ng of recircularized BKV DNA, whereas NIH 3T3 cells were transfected by a modified calcium-DNA coprecipitation method using 400 ng DNA (Luthman & Magnusson, 1983) . Transfections were performed triplicate in three different series of experiments to ensure reproducibility.
Forty-eight hours after transfections the Vero cells were overlaid with 15 % carboxymethyl cellulose in order to prevent secondary spread of virus from the initially transfected cells. An indirect immunoperoxidase staining method was applied to quantify the number of Vero cells expressing BKV structural proteins (Fla~gstad & Traavik, 1987) , using rabbit antisera against purified BKV virions as primary antibodies (Christie et al., 1987) .
NIH 3T3 cells were seeded as a suspension in 0.35% SeaPlaque agarose onto 35 mm wells (1000 cells/well) containing 0.7 % solidified agarose for examination of transformational potential. Colonies were counted after 3 weeks of growth. NIH 3T3 cells stably transformed with v-src served as a positive control. Mock-and pUC18-transfected cells were used as negative controls in both Vero and NIH 3T3 transfections.
Results

The B K V stock preparation is heterogeneous and contains at least seven new N C C R variants
PCR amplification of NCCRs in the viral stock preparation generated several DNA products ranging from approximately 760-520 bp (Fig. 2) . Isolation, cloning and subsequent sequencing of the individual DNA products revealed that the BKV (Gardner) stock contained at least seven different subpopulations of BKV NCCRs. The O-P Q-R-S anatomy and the sequences from these new variants, as well as from BK(WW), BKV (TU), BKV (Gardner) and BKT-1B are given in Fig. 3 . None of the isolated NCCRs were identical to that of BKV (Gardner) , or to the integrated BKT-1B NCCR or any other published variant. All these new NCCR variants have intact O m block sequences, with one exception (see below). One of the NCCRs has intact P68-Q39-S~3 blocks, but totally lacks R-block sequences. This variant was accordingly named PQ and has an identical NCCR anatomy to the described laboratory constructed p8303/p8326 clones (Hara et al., 1985) , d1504 (Watanabe & Yoshiike, 1985) and the pBK68 clone (Deyerle & Subramani, 1988) . All the others have duplications and/or deletions of the sequence blocks, and were named CRV (control region variant) 101 to 106. CRV103 and CRV106 totally lack R-block sequences. The latter is similar but not identical to the published BKV (Gardner) NCCR (Dhar et al., 1978; Yang & Wu, 1979a) , in having triplicated P-block sequences. The middle P-block of BKV (Gardner) has an 18 bp deletion, removing nucleotides 8 to 25, whereas the middle P-block of CRV106 lacks the first 13 nucleotides (Fig. 3b) . The last four CRVs (101, 102, 104 and 105) Fig. 3 . Nucleotide sequence of BKV WWcon. (a) The consensus sequence is based upon previously published WW NCCR sequences (Rubinstein et al., 1987; Sundsfjord et al., 1990; Fbegstad et al., 1991 , Markowitz et al., 1991 Negrini et al., 1991) . The promoter/enhancer region have been arbitrarily divided into sequence blocks called P, Q and R (Markowitz & Dynan, 1988) . Also included are the origin of replication (O) and the late leader designated S. The number of nucleotides in each sequence block and the orientation with respect to early and late expression are indicated. (b) Comparison of the different BKV NCCR variants used. The structure of the archetype WW is presented using the P, Q, R and S nomenclature. The numbers in parenthesis indicate the length of each sequence block in base pairs (Markowitz & Dynan, 1988; Ferguson & Subramani, 1994; Sundsljord et al., 1994) . contain R-block sequences. All are unique, but CRV105 is evidently related to the previously published NCCR variant BKV9, which was cloned from a preparation of BKV (Gardner) after passage in PHFG cells (Chuke et al., 1986) . CRV105 is unique in two respects: it has duplicated S-block sequences and a 1 bp deletion in the O-block. The integrated BKT-1B NCCR is heavily rearranged and only distantly related to any previously * Sequence analysis was performed using the GCG Sequence Analysis Software Package 7.3 (Ghosh, 1990) . Analysis allowing no mismatches was used to identify the transcription factor binding sites created at junctions between the sequence blocks.
t Key: M = A or C; N = A or C or G or T; R = A or G; W = A or T.
published variant, however it is related to CRV101 and CRV104 in having the distal QI_~5-Rla 6a-S6a configuration (see Fig. 3 
b).
A closer look at the sequences of the different blocks in the NCCR variants revealed only three mutations when compared with the consensus sequence based on the published WW sequences (Rubinstein et al., 1987; Sundsfjord et al., 1990; Fl~egstad et al., 1991 ; Markowitz et al., 1991 ; Negrini et al., 1991) . CRV105 has a deletion in the O-block that removes nucleotide 127. CRV106 has a point mutation (AG3-~G) in its first P-block, whereas BKT-1B has a transition (A4G-+G) in the R~a~47 segment. No mutations were found in the Q-or S-block for any of the variants described here.
The new NCCR variants confer divergent host cell permissivity and transforming potential to BKV
In order to investigate the biological properties of the new BKV NCCRs and to compare them with some previously sequenced NCCRs, we developed a cassette model for cloning any NCCR variant into a common genomic background of BKV protein-coding sequences. The resultant recombinant viral genomes were transfected into both semi-permissive Vero cells and nonpermissive NIH 3T3 cells for the examination of viral permissivity and transforming capacity, respectively. As shown in Table 1 , considerable differences were detected between individual NCCR variants in both their ability to propagate in Vero cells and to transform NIH 3T3 to anchorage-independent growth in soft agarose.
The recombinant BKV with the TU NCCR, which was used as a reference strain, multiplied most efficiently in Vero cells, giving a final result of 2.2 x 104 BKVproducing cells/tag transfected DNA at day 21 after transfection. CRV103 also grew reasonably well, with an efficiency which was approximately 46 % of that of BKV (TU). The only difference between this variant and PQ, which had no activity in Vero cells, is the insertion of a Q1 25-P19-~8 sequence, which hence may contain cisacting elements with positive functions.
The efficiency of the other NCCRs tested was low compared to that of BKV (TU). WWT and PQ showed no viral multiplication at all. CRV104 demonstrated 5%, BKT-1B 4% and CRV105 only 1.4% efficiency compared with BKV (TU). It is interesting to note that CRV104 multiplied to some extent. This NCCR variant may be viewed as a simple deletion mutant compared to BKV (WWT) (Fig. 3 b) , which showed no activity at all (Table 1 ). This strongly indicates that the deletion, which removes distal Q and proximal R sequences, may contain cis-acting elements with negative function in Vero cells (see Discussion).
In order to reveal differences in transforming capacities conferred by NCCR variants, the recombinant BKV genomes were transfected into N1H 3T3 cells, which were then tested for the ability to form colonies in soft agarose. In these experiments a clone of the same NIH 3T3 stock, stably transformed with the powerful transforming oncogene v-src All the other NCCR variants tested were also transforming to some degree, with efficiencies ranging from 1% (CRV104) to 9% (TU). The BKT-1B variant, which was found integrated in the hamster fibrosarcoma cell line, had an intermediate transformation efficiency (4 %) in this assay.
The evolution and sequence characteristics of the new BKV NCCR variants
Sequence alignments of the new NCCR variants with each other, and with two key NCCR variants, BKV (Gardner) and the archetype BKV (WW) (Rubinstein et al., 1987; Sundst~ord et al., 1990 Sundst~ord et al., , 1994 Fl~egstad et al., 1991 ; Markowitz et al., 1991 ; Negrini et at., 1991) , give some striking indications about origins and evolutionary relationships (Fig. 3 b) . Comparisons of the new sequence block junctions that have been created, and conserved, strengthen these indications further (Table 2) . Taken together, the results led us to the model outlined in Fig.  4 . The model assumes that an archetypal, BKV (WW)-like, strain has been present in the viral stock at some earlier stage of the passage history (see Discussion). For the sake of completeness, the variant PQ has been (Ghosh, 1990) included in the model. However, a recombinant BKV with this NCCR does not grow in Vero cells. PQ may therefore represent an end stage rather than an intermediate. The variants CRV103 and CRV106 can, however, easily be conceived as being derived from BKV (WW) by two independent events. The variants CRV102 and CRV104 may have evolved directly from BKV (WW) by two independent deletion events. CRV 101 may have evolved from CRV104, and CRV105 from CRV102, by consecutive duplication and deletion events. This conclusion is strengthened by the presence of the conserved Qr 25/R13 63 (CRV104 and 101) and Q1 2~/R55-6a (CRV102 and 105) junctions. Such junctions are rare among the previously sequenced NCCR variants, but the former is present in the integrated BKT-1B and the latter in BKV9 (Chuke et al., 1986) . The biological importance of BKV NCCR variation probably ties with the resultant divergence in number, types and interdistance of cis-acting binding motifs for trans-acting factors (reviewed in Markowitz et al., 1990) . Previous studies (Nowock et al., 1985; Grinnell et al., 1988; Markowitz & Dynan, 1988; Chakraborty & Das, 1991 ; Moens et al., 1994) have proven functional binding of the transcription factors Spl (Qa~-39), AP-I (P-P junction), NF-1 (P24-38, Ps-s/2r 3s in the P-block with internal 18 bp deletion, at the PQ junction, R32 46, R52_63 , $31_~ and 862_~gnogene) , the oestrogen receptor, the progesterone receptor and the glucocorticoid receptor (distal part of S-block). We deduced the number of binding sites for these proven transcription factors in the NCCR variants discussed here. The results are presented in Table 1 . All strains contain several NF-1 (four to eight) binding motifs, while most of them have a single Spl site. CRV101, 102, 104 and 105 lack an Spl site because they lack the distal sequences of the Q-block. The AP-1 site which is located at the P-P junction is only found in Gardner (two sites) and in CRV106 (one site).
In addition to proven binding motifs, we analysed the NCCR for the presence of fully consensus c/s-acting elements for known transcription factors. These results are summarized in Table 3 . Some binding motifs are present at the junctions of the different sequence blocks (AP-1 at the P-P junction, Spl at the P-Q junction). This prompted us to examine aberrant sequence junctions for the presence of putative binding motifs. The results are summarized in Table 3 . Some new binding motifs were created, but their biological significance remains to be investigated.
Discussion
The first isolation of BKV was made after inoculation of Veto cells with urine from a renal allograft recipient on immunosuppressive therapy (Gardner et al., 1971) . In 1978, following many cell culture passages, an NCCR from a stock of this isolate was sequenced (Dhar et al., 1978; Yang & Wu, 1979a) . BKV with such NCCR sequence was thereafter termed prototype BKV (reviewed by Howley, 1980) . Our experiments were based on a cell culture passaged 'prototype' BKV (Gardner) preparation. This preparation was used to study the oncogenic properties of BKV in hamsters (N/ise et al., 1975) . The BKT-1B cell line established from fibrosarcomas evoked by this supposed BKV (Gardner) was later shown to contain monoclonal, integrated BKV DNA with an NCCR very different from the published BKV (Gardner) sequence (Dhar et al., 1978; Yang & Wu, 1979 a) . The presence of R-block sequences, totally absent in BKV (Gardner) , made it clear that the integrated BKV DNA could not have evolved from the Gardner strain.
Our NCCR analysis of the stock virus preparation strongly indicates that neither BKV (Gardner) nor the integrated BKV BKT-1B NCCRs were present. We found the BKV stock preparation to be heterogeneous and to contain at least seven new CRV variants (PQ, CRV101-106). Previously, other NCCR variants have been isolated from 'Gardner' stocks: BKV9 (Chuke et al., 1986) , P2 , Proto-2 (Rubinstein et al., 1987) and pm522, -526 and -527 (Watanabe et al., 1979; Watanabe & Yoshiike, 1986) . Unlike Gardner, which does not contain R-block sequences, BKT-1B, CRV101, CRV102, CRV104, CRV105, BKV9 and P2 do. Mixed infection studies with NCCR variants of another polyomavirus (SV40) have shown that illegitimate recombination between heterologous virus genomes can give rise to new variants (Clarke & Herr, 1987) . Fig. 4 outlines a hypothetical model for the generation of these new NCCR. The model is based on the assumption that an archetypal BKV (WW)-like strain, although never detected by us, must have been present in earlier passages of the stock or in the urine of the patient from which BKV (Gardner) was originally isolated (Gardner et al., 1971 ). This is not unlikely since BKV (WW)-like strains have been isolated from human urine on many occasions (Rubinstein et al., 1987; Sundsfjord et al., 1990 Sundsfjord et al., , 1994 Fl~egstad et al., 1991; Markowitz et al., 1991 ; Negrini et al., 1991) . All strains can be derived from BKV (WW) through deletion and duplication events. Deletion of the complete R-block created the PQ variant. This strain forms the rudiments for BKV (Gardner) , CRV103 and CRV106. Two duplications, with partial deletions in the middle Pblock, gave rise to BKV (Gardner) and CRV106. Partial duplication of the P-and Q-block in the PQ variant created CRV103. The observation by Watanabe & Yoshiike (1986) that their d1504 strain, which has a PQ NCCR anatomy, gave rearranged control regions after passage in human embryonic kidney cells support this assumption. Variants CRV101, 102, 104 and 106 were generated from the WW archetype. Deletion of Q-R sequences created CRV102 and CRV104. Further duplications and deletions led to the genesis of CRV105 and CRV101, respectively. This conclusion is strengthened by the conserved QI_~5-R14 63 (CRV104 and CRV101) and Ql_2~-R55_63 (CRV102 and CRV105)junctions. The former junction is also found in the previously described strains E, KS85, KS122 (Negrini et al., 1990) , IR (Pagnani et al., 1986) , and BKT-1B , while the latter junction is also present in BKV9 (Chuke et al, 1986 ) and P2 .
Employment of the described cassette cloning technique will make it feasible to compare the biological characteristics contributed to BKV by any NCCR variant, and in any transfectable cell type. As illustrated by the sequence analyses of the new NCCR variants and our experiments with recombinant viruses in Vero and NIH 3T3 cells, even rather simple duplication/deletion events may have dramatic biological consequences. Sequence comparisons between NCCR variants that must be evolutionarily very closely related, but showed very divergent biological characteristics, gave us the ability to identify sequences and cis-acting sequence elements that may positively and negatively contribute to divergent Vero cell permissivity. This opportunity was offered by comparisons between two sets of NCCR variants: CRV102 and CRV104 are simple deletion mutants of BKV (WWT), whereas CRV103 is an insertion mutant of the PQ NCCR variant. In both cases the mutations provide gain of activity compared to the 'parental' NCCRs, which are both totally inactive in Vero cells. Consequently, we may directly deduce that deletion of the sequence Q26_z9-Rl_13 (CRV104) seems to remove cis-acting elements with a negative effect on the archetypal BKV (WWT). On the other hand, by comparing the NCCR variants WWT and PQ, it becomes evident that deletion of the whole R-block does not result in any gain of activity. However, deletion of the whole R-block combined with a partial duplication of P/Q sequences (Qx_~5-P19_6s) gives rise to CRV103 with a considerable activity in Vero cells. Based on computerized searches we have made efforts to identify responsible cis-acting elements/trans-acting factors. A listing of the putative consensus elements removed or added by these deletion and duplication processes are given in Table 2 . However, this does not allow us to draw any definite conclusions at present. It should also be noted that many trans-acting factor binding motifs allow at least one mismatch, making the situation even more complex. Only further, focused experimental studies may identify the exact cis-acting sequence motifs responsible for the observed positive and negative effects on Vero cell permissivity.
All the NCCR variants tested, irrespective of their permissivity in Vero cells, had a significant capacity to transform NIH 3T3 cells. The outstanding performer in this context was CRV105, which may be viewed as an insertion mutant of CRV102 (see Fig. 4 ). The insertion (S1 36-P60-68-Ql-~s-R~ G3) seems to diminish the efficiency in Vero cells, but distinctly enhances the transforming potential, which was three-to fivefold higher than for any of the other NCCR variants. It has been reported that decreasing the number of P-blocks enhances transforming ability (Watanabe & Yoshiike, 1985) . This indicates that the duplicated S-block sequences may be responsible for the higher transforming capacity of the CRV105 variant. The only other variant containing repeated S-block sequences is BKV9 (Chuke et al., 1986) . This strain has an six-to sevenfold higher transformation efficiency than BKV (Gardner) in Rat-2 cells (Tavis et al., 1990 ).
In conclusion, seven new BKV NCCR variants have been isolated from a BKV (Gardner) stock, none of them being Gardner. Comparative studies of these variants within the same protein-coding background revealed biological differences which are probably the result of the creation or removal of binding motifs for known transacting factors. Only further, focused experimental studies may identify which of these cis-acting sequence motifs are functional.
